4
Changes in Ownership
Greenwich LifeSciences, Inc. Filed Acc 0001493152-25-000151
CEO and CFO bought 2,400 shares at $11.36 ($27,264)
From the SEC's structured data for this filing
Trades in this filing
Patel Snehal · CEO and CFO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-12-31 | Purchase : show line 1 in the form | +2,400 | $11.36 | $27,264 | 5,541,702 | D |
| Open-market purchases · 2,400 sh · avg $11.36 · $27,264 | ||||||
Loading xslF345X05/ownership.xml…